James Ferguson

Chief Tech/Sci/R&D Officer at CADRENAL THERAPEUTICS, INC.

72 year

Health Technology

Consumer Services

Health Services

Profile

James J.
Ferguson is Chief Medical Officer at Cadrenal Therapeutics, Inc. since 2025.
Formerly, Chief Medical Officer at Matinas BioPharma Holdings, Inc. from 2019 to 2024.
Head-Cardiovascular & Bone Therapeutic at Amgen, Inc. from 2016 to 2019.
Vice President-Global Medical Affairs at AstraZeneca PLC from 2010 to 2016.
VP-Global Medical, Surgical & Critical Care at The Medicines Co. from 2009 to 2010.
Associate Director-Clinical Cardiology Research at Texas Heart Institute from 1987 to 2008.
Director-Cardiology Fellowship Training Program at St. Luke's Episcopal Hospital.
Associate Professor at Baylor College of Medicine.
Clinical Assistant Professor at The University of Texas Health Science Center at Houston.
Education includes undergraduate degree from Harvard University and doctorate from the University of Pennsylvania Medical Center.

James Ferguson active positions

Companies	Position	Start
CADRENAL THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	06/02/2025

All active positions of James Ferguson

Former positions of James Ferguson

Companies	Position	End
MATINAS BIOPHARMA HOLDINGS, INC.	Chief Tech/Sci/R&D Officer	31/10/2024
AMGEN INC.	Corporate Officer/Principal	01/01/2019
ASTRAZENECA PLC	Corporate Officer/Principal	01/08/2016
THE MEDICINES COMPANY	Corporate Officer/Principal	01/05/2010
Texas Heart Institute Texas Heart Institute Hospital/Nursing ManagementHealth Services Provides an avenue for exchange of ideas relating to the clinical and research activities	Corporate Officer/Principal	01/01/2008

See the detail of James Ferguson's experience

Training of James Ferguson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Ferguson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
The Medicines Co. The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care	Health Technology
Matinas BioPharma Holdings, Inc. Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
St. Luke's Episcopal Hospital St. Luke's Episcopal Hospital Hospital/Nursing ManagementHealth Services Provides medical and health care services	Health Services
Baylor College of Medicine Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Texas Heart Institute Texas Heart Institute Hospital/Nursing ManagementHealth Services Provides an avenue for exchange of ideas relating to the clinical and research activities	Health Services
University of Pennsylvania Medical Center University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Texas Health Science Center at Houston The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cadrenal Therapeutics, Inc. Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication	Health Technology